Table 4. Prevalence and odds ratio of current wheezing and current allergic rhinitis in selected group.
Characteristics | Current wheezing | Asthma ever | Current rhinitis symptoms | Current rhino-conjunctivitis symptoms | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
% | COR (95% CI) | p | % | COR (95% CI) | p | % | COR (95% CI) | p | % | COR (95% CI) | p | |
Sex | ||||||||||||
Female | 3 | 1.15 (0.70–1.90) | 0.589 | 3.7 | 2.67(1.46–4.86) | 0.001 | 10.7 | 1.09 (0.83–1.43) | 0.504 | 5.8 | 1.21(0.83–1.75) | 0.322 |
Male | 2.6 | 1 | 1.4 | 1 | 10 | 1 | 4.9 | 1 | ||||
Age group, years | ||||||||||||
19–30 | 3.3 | 0.68 (0.30–1.54) | 0.297 | 3.1 | 1.1250.39–3.18) | 0.839 | 11.3 | 1.40 (0.76–2.61) | 0.282 | 6.5 | 1.37(0.62–3.02) | 0.443 |
31–40 | 1.4 | 0.29 (0.10–0.81) | 0.018 | 2.4 | 0.86(0.27–2.71) | 0.798 | 9.8 | 1.20 (0.62–2.31) | 0.597 | 3.6 | 0.73(0.30–1.79) | 0.492 |
41–50 | 3 | 0.61 (0.22–1.67) | 0.336 | 3 | 1.09(0.33–3.60) | 0.888 | 8.7 | 1.05 (0.51–2.15) | 0.891 | 3 | 0.61(0.22–1.67) | 0.336 |
51–60 | 2 | 0.41 (0.12–1.42) | 0.408 | 1 | 0.36(0.07–2.00) | 0.243 | 10.7 | 1.32 (0.63–2.78) | 0.465 | 7.7 | 1.62(0.64–4.09) | 0.305 |
> 60 | 4.9 | 1 | 2.8 | 1 | 8.3 | 1 | 4.9 | 1 | ||||
Level of education | ||||||||||||
< secondary | 3.1 | 0.94 (0.48–1.87) | 0.867 | 2.6 | 0.79(0.39–1.64) | 0.533 | 9.2 | 1 | 5.9 | 1 | ||
secondary | 2.6 | 0.78 (0.45–1.35) | 0.373 | 2.5 | 0.75(0.43–1.31) | 0.312 | 8.8 | 0.95 (0.65–1.40) | 0.797 | 4.4 | 0.86(0.53–1.42) | 0.564 |
Higher education | 3.3 | 1 | 3.3 | 1 | 13.7 | 1.56 (1.06–2.31) | 0.025 | 6.8 | 1.58(1.05–2.36) | 0.027 | ||
Ethnic group | ||||||||||||
Bantou | 3.2 | 2.11 (0.50–8.85) | 0.308 | 3 | 1.32(0.40–4.35) | 0.648 | 11 | 1.89 (0.90–3.94) | 0.092 | 5.8 | 1.27(0.54–2.99) | 0.582 |
Semi-Bantou | 2.7 | 1.76 (0.41–7.52) | 0.444 | 2.4 | 0.97(0.29–3.29) | 0.964 | 10.4 | 1.77 (0.84–3.73) | 0.132 | 5.2 | 1.12(0.47–2.67) | 0.793 |
Peul/Sudanese | 1.5 | 1 | 3 | 1 | 6.2 | 1 | 4.6 | 1 | ||||
Marital status | ||||||||||||
Living in couple | 2.4 | 1 | 1.9 | 1 | 9 | 1 | 4.1 | 1 | ||||
Alone | 3.2 | 1.36 (0.79–2.33) | 0.263 | 3.3 | 1.77(0.98–3.18) | 0.054 | 11.3 | 1.30 (0.97–1.74) | 0.079 | 6.2 | 1.54(1.02–2.31) | 0.038 |
Number/chamber in household (n = 2232) | ||||||||||||
≤ 2 | 3.2 | 1.29 (0.78–2.13) | 0.321 | 3 | 1.27(0.76–2.12) | 0.356 | 11.2 | 1.201 (0.92–1.58) | 0.174 | 5.6 | 1.06(0.74–1.53) | 0.749 |
> 2 | 2.5 | 1 | 2.4 | 1 | 9.5 | 1 | 5.3 | 1 | ||||
Tobacco smoking (n = 2298) | ||||||||||||
smokers | 3.1 | 1.09 (0.39–3.07) | 0.861 | 1.5 | 0.51(0.16–1.64) | 0.259 | 19.4 | 2.21 (1.39–3.50) | 0.001 | 8.2 | 1.70(0.98–2.95) | 0.058 |
Ex-smokers | 3.1 | 1.09 (0.47–2.57) | 0.837 | 0.8 | 0.25(0.04–1.85) | 0.176 | 10.8 | 1.11 (0.69–1.80) | 0.656 | 7.8 | 1.59(0.81–3.13) | 0.178 |
Non-smokers | 2.8 | 1 | 3 | 1 | 9.8 | 1 | 5 | 1 | ||||
History of pulmonary TB | ||||||||||||
Yes | 2.2 | 0.77 (0.10–5.65) | 0.794 | 4.4 | 1.68(0.39–7.08) | 0.477 | 11.1 | 1.08 (0.42–2.76) | 0.878 | 2.2 | 0.39(0.05–2.84) | 0.388 |
No | 2.9 | 1 | 2.7 | 1 | 10.4 | 1 | 5.5 | 1 | ||||
BMI, kg/m 2 (n = 2280) | ||||||||||||
≥ 30 | 3 | 0.96 (0.53–1.72) | 0.88 | 3.4 | 1.35(0.77–2.38) | 0.300 | 10.6 | 1.04 (0.75–1.43) | 0.834 | 4.4 | 0.77(0.48–1.23) | 0.276 |
< 30 | 2.9 | 1 | 2.5 | 1 | 10.2 | 1 | 5.6 | 1 | ||||
Current eczema symptoms | ||||||||||||
Yes | 9.4 | 3.74 (1.44–9.72) | 0.016 | 5.7 | 2.19(0.67–7.22) | 0.175 | 26.4 | 3.22 (1.72–6.02) | <0.001 | 18.9 | 4.32(2.12–8.81) | <0.001 |
No | 2.7 | 1 | 2.7 | 1 | 10 | 1 | 5.1 | 1 | ||||
Current rhinitis | / | / | / | / | / | / | ||||||
Yes | 7.5 | 3.41 (1.95–5.96) | <0.001 | 6.7 | 3.07(1.71–5.50) | <0.001 | / | / | / | ./ | / | / |
No | 2.3 | 1 | 2.3 | |||||||||
Current wheezing | ||||||||||||
Yes | / | / | / | 30.3 | 22.19(12.11–40.67) | <0.001 | 27.3 | 3.41 (1.95–5.96) | <0.001 | 20 | 4.70(2.49–8.89) | <0.001 |
No | / | / | / | 1.9 | 1 | 9.9 | 1 | 5 | 1 | |||
Asthma ever | ||||||||||||
Yes | 31.7 | 22.19(12.11–40.66) | <0.001 | / | / | / | 25.4 | 3.41 (1.95–5.96) | <0.001 | 15.9 | 3.46(1.71–6.97) | <0.001 |
No | 2.1 | 1 | / | / | / | 10 | 5.2 | 1 |
CI, confidence interval; CRO, crude odds ratio; BMI, body mass index; TB, tuberculosis.